These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10720639

  • 1. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J, Zushida K, Ohsawa M, Nagase H.
    Eur J Pharmacol; 2000 Mar 10; 391(1-2):91-6. PubMed ID: 10720639
    [Abstract] [Full Text] [Related]

  • 2. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1995 Feb 24; 275(1):109-13. PubMed ID: 7774657
    [Abstract] [Full Text] [Related]

  • 3. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
    Kamei J, Morita K, Saitoh A, Nagase H.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):219-22. PubMed ID: 12706478
    [Abstract] [Full Text] [Related]

  • 4. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H, Kampine JP.
    J Pharmacol Exp Ther; 2000 Feb 25; 292(2):576-83. PubMed ID: 10640294
    [Abstract] [Full Text] [Related]

  • 5. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2000 Sep 25; 294(3):1106-11. PubMed ID: 10945866
    [Abstract] [Full Text] [Related]

  • 6. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, Narita M, Suzuki T, Tan-no K, Tseng LF.
    Eur J Pharmacol; 2001 Sep 21; 427(3):203-10. PubMed ID: 11567650
    [Abstract] [Full Text] [Related]

  • 7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D, Watanabe C, Watanabe H, Mizoguchi H, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):109-16. PubMed ID: 17343845
    [Abstract] [Full Text] [Related]

  • 8. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K, Onodera K, Kamei J.
    Eur J Pharmacol; 2002 Oct 25; 453(2-3):209-15. PubMed ID: 12398906
    [Abstract] [Full Text] [Related]

  • 9. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
    Sakurada S, Sawai T, Mizoguchi H, Watanabe H, Watanabe C, Yonezawa A, Morimoto M, Sato T, Komatsu T, Sakurada T.
    Peptides; 2008 Sep 25; 29(9):1554-60. PubMed ID: 18571771
    [Abstract] [Full Text] [Related]

  • 10. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Neurosci Lett; 1994 Jan 03; 165(1-2):141-3. PubMed ID: 8015716
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C, Saitoh A, Kamei J.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):145-51. PubMed ID: 16533506
    [Abstract] [Full Text] [Related]

  • 12. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
    Kamei J, Saitoh A, Kasuya Y.
    Neurosci Lett; 1995 Aug 25; 196(3):169-72. PubMed ID: 7501275
    [Abstract] [Full Text] [Related]

  • 13. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T.
    Brain Res; 2000 Oct 20; 881(1):1-8. PubMed ID: 11033087
    [Abstract] [Full Text] [Related]

  • 14. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec 20; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 20; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 16. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S, Zadina JE, Kastin AJ, Katsuyama S, Fujimura T, Murayama K, Yuki M, Ueda H, Sakurada T.
    Eur J Pharmacol; 1999 May 07; 372(1):25-30. PubMed ID: 10374711
    [Abstract] [Full Text] [Related]

  • 17. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.
    Eur J Pharmacol; 2000 Apr 28; 395(2):107-12. PubMed ID: 10794815
    [Abstract] [Full Text] [Related]

  • 18. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C, Saitoh A, Tamura N, Kamei J.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):75-9. PubMed ID: 16256106
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y, Fujita Y, Shiotani K, Miyazaki A, Li T, Tsuda Y, Okada Y, Ambo A, Sasaki Y, Bryant SD, Lazarus LH.
    Eur J Pharmacol; 2005 Feb 10; 509(1):37-42. PubMed ID: 15713427
    [Abstract] [Full Text] [Related]

  • 20. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A, Baiula M, Gentilucci L, Tolomelli A, De Marco R, Spampinato S.
    Peptides; 2010 Nov 10; 31(11):2135-40. PubMed ID: 20713109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.